These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25506873)

  • 1. QBleed predicted risk for gastrointestinal and intracranial bleeding.
    Hankey GJ
    Ann Intern Med; 2014 Dec; 161(12):JC13. PubMed ID: 25506873
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores.
    Hippisley-Cox J; Coupland C
    BMJ; 2014 Jul; 349():g4606. PubMed ID: 25069704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined bleeding estimates in adults starting anticoagulants.
    Steinberg BA
    BMJ; 2014 Jul; 349():g4800. PubMed ID: 25073683
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleeding related to non-vitamin K antagonist oral anticoagulants in emergency department: A "Real-world" snapshot from Southern Italy. On behalf of MIRC-NOAC study group.
    Salzano A; Proietti M; D'Assante R; Saldamarco L; Cittadini A; Paladino F
    Eur J Intern Med; 2018 Feb; 48():e21-e24. PubMed ID: 29102387
    [No Abstract]   [Full Text] [Related]  

  • 5. High INR on warfarin.
    Reddy U; Mallepaddi NR; Chevassut TJ
    BMJ; 2015 Apr; 350():h1282. PubMed ID: 25858914
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal bleedings with prasugrel as part of triple antithrombotic therapy.
    Savonitto S; Ferri M; Corrada E
    Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):225-6. PubMed ID: 24774401
    [No Abstract]   [Full Text] [Related]  

  • 7. Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
    Jolobe OM
    Br J Hosp Med (Lond); 2017 Jul; 78(7):416. PubMed ID: 28692369
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
    Sam C; Massaro JM; D'Agostino RB; Levy D; Lambert JW; Wolf PA; Benjamin EJ;
    Am J Cardiol; 2004 Oct; 94(7):947-51. PubMed ID: 15464686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation in acute stroke with atrial fibrillation. Five questions should be answered before the treatment can be considered evidence-based].
    Terént A; Åsberg S; Hijazi Z
    Lakartidningen; 2014 May 14-20; 111(20):872-4. PubMed ID: 24908802
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials.
    Vanassche T; Hirsh J; Eikelboom JW; Ginsberg JS
    Thromb Haemost; 2014 Nov; 112(5):918-23. PubMed ID: 25187203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of blood coagulation factors between patients with gastrointestinal or intracranial bleeding under vitamin K antagonists.
    Moustafa F; Saint-Denis J; Laporte S; Mismetti P; Schmidt J
    Eur J Intern Med; 2016 Sep; 33():e22-4. PubMed ID: 27209417
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral anticoagulants and the risk of intracranial hemorrhage.
    Vespa PM
    JAMA; 2014 Dec; 312(23):2562-3. PubMed ID: 25514305
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and risks of aspirin use.
    Lund JL; Stürmer T; Toft-Sørensen H
    JAMA; 2012 Sep; 308(11):1089-90; author reply 1090. PubMed ID: 22990258
    [No Abstract]   [Full Text] [Related]  

  • 15. Benefits and risks of aspirin use.
    DiNicolantonio JJ; O'Keefe JH; Lavie CJ
    JAMA; 2012 Sep; 308(11):1088-9; author reply 1090. PubMed ID: 22990257
    [No Abstract]   [Full Text] [Related]  

  • 16. New oral anticoagulants and the risk for intracranial hemorrhage.
    Kallistratos MS; Poulimenos LE; Manolis AJ
    JAMA Neurol; 2014 Mar; 71(3):370-1. PubMed ID: 24614992
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency admissions for major haemorrhage associated with direct oral anticoagulants.
    Bouget J; Oger E
    Thromb Res; 2015 Dec; 136(6):1190-4. PubMed ID: 26545315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.
    Serna MJ; Rivera-Caravaca JM; Gonzalez-Conejero R; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Roldán V; Marín F
    Eur J Clin Invest; 2018 Jun; 48(6):e12929. PubMed ID: 29577257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis.
    Bleker SM; Brekelmans MPA; Eerenberg ES; Cohen AT; Middeldorp S; Raskob G; Büller HR
    Thromb Haemost; 2017 Oct; 117(10):1944-1951. PubMed ID: 28816341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.